Interview by Nicola Miller RARE Revolution,
Featuring Brandon Cieniewicz, director,CERo Therapeutics

“Getting back to this disease [AML] with high unmet need and being able to come up with something new and bring it through clinical trial, has been very rewarding.” Brandon